ASCENTAWITS
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs. The company utilizes specific tumor micro-environments to carry out independent innovative drug designs and screening for the development of new anti-tumor drugs.
ASCENTAWITS
Industry:
Biotechnology Medical Pharmaceutical Product Research
Founded:
2017-01-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.ascentawits.com
Total Employee:
51+
Status:
Active
Contact:
0755-27888161
Total Funding:
200 M CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Mobile Non Scaleable Content Pound Sterling Japanese Yen
Similar Organizations
Doublle Bioproduct
Doublle Bioproduct focuses on the research and development of anti-tumor drugs.
Etern
Etern is a biopharma company.
GeneFrontier
Gene Frontier took a new step as a member of the Kaneka Group.
Pro-Cure Therapeutics
Pro-Cure Therapeutics is focused on developing drugs targeted against cancer stem cells.
Stempeutics Research
Stempeutics Research focuses on developing and commercializing novel therapeutics based on adult stem cells.
Tyercan
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
Investors List
Sangel Capital
Sangel Capital investment in Series A - Ascentawits
CICC
CICC investment in Series A - Ascentawits
Kangchengheng Touzi
Kangchengheng Touzi investment in Series A - Ascentawits
Cowin Capital
Cowin Capital investment in Series A - Ascentawits
Shenzhen Guozhong Venture Capital Management
Shenzhen Guozhong Venture Capital Management investment in Series A - Ascentawits
Essence Capital
Essence Capital investment in Series A - Ascentawits
Kangchengheng Touzi
Kangchengheng Touzi investment in Series A - Ascentawits
BGI Co-Win
BGI Co-Win investment in Series A - Ascentawits
Official Site Inspections
http://www.ascentawits.com
- Host name: 120.78.166.66
- IP address: 120.78.166.66
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Ascentawits"
Ascentawits - Crunchbase Company Profile & Funding
Organization. Ascentawits . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Ascentawits focuses on developing small …See details»
深圳艾欣达伟医药科技有限公司
Global Pioneer of Small Molecule-Drug Conjugates. 全球小分子靶向偶联药物开拓者See details»
Ascentawits Pharmaceuticals Ltd. - Drug pipelines, Patents, Clinical ...
Explore Ascentawits Pharmaceuticals Ltd. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 2 news, and 6 literature, Disease Domain:Neoplasms, Endocrinology …See details»
Ascentawits Pharmaceutical - PitchBook
Ascentawits Pharmaceutical General Information Description. Developer of anti-tumor drugs. The company utilizes specific tumor micro-environments to carry …See details»
Ascentawits - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 11, 2021: Series A - …See details»
Ascentawits Pharmaceuticals - 2025 Company Profile - Tracxn
5 days ago Shenzhen Ascentawits Pharmaceuticals is involved in the development of anti-tumor drugs. The company uses a tumor microenvironment for prodrug design and screening and …See details»
ASCENTAWITS, A World Intellectual Property Organization …
ASCENTAWITS is a WIPO trademark and brand of ASCENTAWITS PHARMACEUTICALS, LTD., Room 1003, 10th Floor, Building 10,, Biomedical Innovation Industrial Park,, No.14 Jinhui …See details»
Ascentawits - Crunchbase
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs.See details»
Ascentawits Pharmaceuticals - VentureRadar
Shenzhen Ascentawits Pharmaceuticals, LTD. is a biopharmaceutical technology company in the clinical stage, focusing on the research and development of innovative small molecule …See details»
深圳艾欣达伟医药科技有限公司 - ascentawits.com
深圳艾欣达伟医药科技有限公司（Ascentawits Pharmaceuticals, LTD.）是一家处于临床阶段，专注于小分子靶向偶联创新药物研发的生物医药科技企业。 公司自成立以来始终坚持通过原研创新技术，围绕着全新靶点，自主开发以临床急需为 …See details»
Ascentawits Pharmaceuticals - Products, Competitors, Financials ...
Ascentawits Pharmaceuticals is a company focused on the development of small molecule-drug conjugates within the pharmaceutical industry. Use the CB Insights Platform to explore …See details»
Ascentawits Pharmaceuticals Ltd. (深圳艾欣达伟医药科技有限公司) …
了解Ascentawits Pharmaceuticals Ltd. (深圳艾欣达伟医药科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的8项临床试验, 2篇新闻和7篇文献，疾病领域:肿瘤，内分泌与代谢疾 …See details»
Ascentawits self-developing first-in-class drugs - EYESHENZHEN
Ascentawits Pharmaceuticals Ltd., located in Pingshan, Shenzhen, is engaged in the R&D of small-molecule drug conjugates, a promising approach for targeted cancer therapies. …See details»
深圳艾欣达伟医药科技有限公司 - ascentawits.com
Feb 27, 2023 2022-12-13 深圳成立生物医药产业基金 药企艾欣达伟获重奖2233万. 12月12日，由深圳市人民政府指导，市发展和改革委员会主办的第八届深圳国际生物医药产业高峰论坛 …See details»
Ascentawits - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
艾欣达伟小分子靶向抗癌新药注射用AST-006 获得NMPA默示许可 …
Jun 29, 2023 关于艾欣达伟 深圳艾欣达伟医药科技有限公司（Ascentawits Pharmaceuticals, Ltd）是一家处于临床阶段，专注于小分子靶向偶联创新药物研发的生物医药科技企业。公司 …See details»
Ascentawits self-developing first-in-class drugs - EYESHENZHEN
Ascentawits now has a 1,400-square-meter R&D center in Pingshan with over 30 professionals engaged in synthesis, testing and production for first-in-class drugs. The center has carried out …See details»
Ascentawits Pharma announced the interim analysis results of the …
AST-3424 study presented on September 27, won the "Outstanding Paper Award" OBI Pharma’s partner, Ascentawits Pharma Ltd., presented the interim results of the Phase II clinical efficacy …See details»
深圳艾欣达伟医药科技有限公司 - ascentawits.com
Oct 19, 2023 深圳艾欣达伟医药科技有限公司（ Ascentawits Pharmaceuticals, Ltd，以下简称“艾欣达伟”或“公司”）今日宣布，公司将在本月20日-24日举行的2023年欧洲肿瘤医学协会会议（ …See details»
Ascentawits - Updates, News, Events, Signals & Triggers
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs.See details»